GURUFOCUS.COM » STOCK LIST » Healthcare » Biotechnology » OptiBiotix Health PLC (LSE:OPTI) » Definitions » Other Net Income (Loss)

OptiBiotix Health (LSE:OPTI) Other Net Income (Loss) : £-0.00 Mil (TTM As of Jun. 2023)


View and export this data going back to 2011. Start your Free Trial

What is OptiBiotix Health Other Net Income (Loss)?

OptiBiotix Health's Other Net Income (Loss) for the six months ended in Jun. 2023 was £0.00 Mil. Its Other Net Income (Loss) for the trailing twelve months (TTM) ended in Jun. 2023 was £-0.00 Mil.

OptiBiotix Health's quarterly Other Net Income (Loss) declined from Jun. 2022 (£0.00 Mil) to Dec. 2022 (£-0.00 Mil) but then increased from Dec. 2022 (£-0.00 Mil) to Jun. 2023 (£0.00 Mil).

OptiBiotix Health's annual Other Net Income (Loss) increased from Dec. 2020 (£0.00 Mil) to Dec. 2021 (£0.00 Mil) but then declined from Dec. 2021 (£0.00 Mil) to Dec. 2022 (£0.00 Mil).


OptiBiotix Health Other Net Income (Loss) Historical Data

The historical data trend for OptiBiotix Health's Other Net Income (Loss) can be seen below:

* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD.
* For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.

* Premium members only.

OptiBiotix Health Other Net Income (Loss) Chart

OptiBiotix Health Annual Data
Trend Jul10 Jul12 Nov14 Nov15 Nov16 Nov17 Nov18 Dec20 Dec21 Dec22
Other Net Income (Loss)
Get a 7-Day Free Trial Premium Member Only Premium Member Only - - - - -

OptiBiotix Health Semi-Annual Data
Jul12 Jan13 May14 Nov14 May15 Nov15 May16 Nov16 May17 Nov17 May18 Nov18 May19 Jun20 Dec20 Jun21 Dec21 Jun22 Dec22 Jun23
Other Net Income (Loss) Get a 7-Day Free Trial Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only - - - - -

OptiBiotix Health Other Net Income (Loss) Calculation

Different companies can and do choose to report each of income statement items separately. Yet, there are a variety of items which are simply too numerous to list. Therefore GuruFocus uses a standardized financial statement format for all companies. Other Net Income (Loss) may include but is not limited to items such as net income (loss) from discontinuing operations, extraordinary, earnings from equity interest net of tax, etc. After-tax income and Other Net Income (Loss) together constitute Net Income Including Noncontrolling Interests.

Other Net Income (Loss) for the trailing twelve months (TTM) ended in Jun. 2023 adds up the semi-annually data reported by the company within the most recent 12 months, which was £-0.00 Mil.

* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD.
* For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.


OptiBiotix Health Other Net Income (Loss) Related Terms

Thank you for viewing the detailed overview of OptiBiotix Health's Other Net Income (Loss) provided by GuruFocus.com. Please click on the following links to see related term pages.


OptiBiotix Health (LSE:OPTI) Business Description

Traded in Other Exchanges
Address
Innovation Centre, Innovation Way, Heslington, York, GBR, YO10 5DG
OptiBiotix Health PLC is engaged in the field of healthcare. As a life science company, its prime focus lies in researching the area of biotechnology. Its activities include the identification of microbial strains, compounds, and formulations for use in food ingredients, supplements, and active compounds that can impact human physiology, deriving potential health benefits. The company derives majority of the revenue from the sale of Functional Fibres. The company markets its products in the United Kingdom under trademark names such as OptiBiotix, SweetBiotix, and SkinBioTherapeutics.